Clinical Trials Logo

Clinical Trial Summary

Aldosterone is a hormone produced in the adrenals that helps regulate the salt balance and blood pressure. Primary hyperaldosteronism is one of the main endocrine causes of secondary hypertension. The overproduction of aldosteron might in some cases be due to unilateral hyperplasia of the adrenal cortex or a unilateral aldosterone-producing adenoma. In these cases the adrenal can be removed and the patient cured of hypertension. The clinical evaluation of patients with confirmed primary hyperaldosteronism therefore includes selective sampling of blood from the adrenal veins to determine lateralization of overproduction. This is executed as an interventional radiological procedure.

The adrenal vein sampling is challenging, and success is determined by measuring another adrenal hormone named cortisol in the blood samples as a marker of a correctly drawn sample. By routine laboratory assays the procedure is evaluated after the patient has been discharged from the hospital. In the study a rapid assay of cortisol will be evaluated, allowing the radiologist to draw new samples during the same procedure if the first set of samples is unsuccessful. The study hypothesis is that intraoperative measurement of cortisol is a useful tool to evaluate successful sampling, and that fewer patients will need a repeated procedure.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01761344
Study type Interventional
Source Haukeland University Hospital
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date August 2013

See also
  Status Clinical Trial Phase
Completed NCT01728493 - Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment N/A
Completed NCT02934399 - Dynamic Hormone Diagnostics in Endocrine Disease
Enrolling by invitation NCT03474237 - A Prospective Cohort Study for Patients With Adrenal Diseases
Completed NCT01978132 - Primary Hyperaldosteronism and Ischemia-reperfusion Injury N/A
Completed NCT02938910 - Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism N/A
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed NCT00732771 - Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism Phase 2
Recruiting NCT05636995 - HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)
Recruiting NCT04251780 - Tissue K+ in Primary Hyperaldosteronism N/A
Completed NCT03405025 - Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas N/A
Completed NCT01567111 - 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism N/A